Hey @Zissou , thanks. What do you think about the FY23 and their potential to get back to previous profitability.
Statutory revenue: $69.8 million, up 11% on pcp , assisted by the TCV growth, but offset by lower services revenue.
Statutory EBITDA was up 42% to $12.1 million.
Net Profit After Tax and before non-cash impairment (NPAT) of $2.6 million
= EBITDA of 17.3% and NPAT of 3.7%
Whereas before in 2019, EBITDA was 40%
Ann: FY2023 Trading Update, page-12
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
-0.010(1.30%) |
Mkt cap ! $132.7M | |||
| Open | High | Low | Value | Volume |
| 77.5¢ | 79.0¢ | 76.0¢ | $132.1K | 169.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22374 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 1020 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IRI (ASX) Chart |